Dilated cardiomyopathy-associatedBAG3mutations impair Z-disc assembly and enhance sensitivity to apoptosis in cardiomyocytes

Arimura, 2009, Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy, J Am Coll Cardiol, 54, 334, 10.1016/j.jacc.2008.12.082

Arimura, 2007, Molecular etiology of idiopathic cardiomyopathy, Acta Myol, 26, 153

Chao, 2005, Lipopolysaccharide improves cardiomyocyte survival and function after serum deprivation, J Biol Chem, 280, 21997, 10.1074/jbc.M413676200

Chua, 2006, Multiple actions of pifithrin-alpha on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells, Am J Physiol Heart Circ Physiol, 290, H2606, 10.1152/ajpheart.01138.2005

Hayashi, 2004, Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy, J Am Coll Cardiol, 44, 2192, 10.1016/j.jacc.2004.08.058

Hishiya, 2010, BAG3 and Hsc70 interact with actin capping protein CapZ to maintain myofibrillar integrity under mechanical stress, Circ Res, 107, 1220, 10.1161/CIRCRESAHA.110.225649

Hishiya, 2011, BAG3 directly interacts with mutated alphaB-Crystallin to suppress its aggregation and toxicity, PLoS One, 6, e16828, 10.1371/journal.pone.0016828

Homma, 2006, BAG3 deficiency results in fulminant myopathy and early lethality, Am J Pathol, 169, 761, 10.2353/ajpath.2006.060250

Inagaki, 2006, Alpha B-crystallin mutation in dilated cardiomyopathy, Biochem Biophys Res Commun, 342, 379, 10.1016/j.bbrc.2006.01.154

Kimura, 2010, Molecular basis of hereditary cardiomyopathy: abnormalities in calcium sensitivity, stretch response, stress response and beyond, J Hum Genet, 55, 81, 10.1038/jhg.2009.138

Lee, 2011, BAG3-related myofibrillar myopathy in a Chinese family, Clin Genet

Lee, 1999, Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death, Oncogene, 18, 6183, 10.1038/sj.onc.1203043

Maron, 2006, Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention, Circulation, 113, 1807, 10.1161/CIRCULATIONAHA.106.174287

Murata, 2003, CHIP: a quality-control E3 ligase collaborating with molecular chaperones, Int J Biochem Cell Biol, 35, 572, 10.1016/S1357-2725(02)00394-1

Naito, 2010, Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury, Circ Res, 106, 1692, 10.1161/CIRCRESAHA.109.214346

Norton, 2011, Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy, Am J Hum Genet, 88, 273, 10.1016/j.ajhg.2011.01.016

Odgerel, 2010, Inheritance patterns and phenotypic features of myofibrillar myopathy associated with a BAG3 mutation, Neuromuscul Disord, 20, 438, 10.1016/j.nmd.2010.05.004

Pratt, 2010, Proposal for a role of the Hsp90/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage, Exp Biol Med, 235, 278, 10.1258/ebm.2009.009250

Selcen, 2009, Mutation in BAG3 causes severe dominant childhood muscular dystrophy, Ann Neurol, 65, 83, 10.1002/ana.21553

Takayama, 1999, An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators, J Biol Chem, 274, 781, 10.1074/jbc.274.2.781

Villard, A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy, Eur Heart J, 32, 1065, 10.1093/eurheartj/ehr105